Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter , Prospective, Randomized, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers

NCT03588130 is registered in ClinicalTrials.gov with MediWound Ltd as lead sponsor.

NCT NCT03588130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03588130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter , Prospective, Randomized, Placebo Controlled, Adaptive Design Study Performed to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers
Lead sponsor
MediWound Ltd
Phase
Phase 2
Overall status
Completed
Start date
December 2, 2019
Completion date
March 23, 2022
Enrollment
120 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer